Lewis K J, Irwin W J, Akhtar S
Pharmaceutical Sciences Institute, Aston University, Birmingham, UK.
J Drug Target. 1998;5(4):291-302. doi: 10.3109/10611869808995882.
Development of a Sustained-Release Biodegradable Polymer Delivery System for Site-Specific Delivery of Oligonucleotides: Characterization of P(LA-GA) Copolymer Microspheres In Vitro Antisense oligodeoxynucleotides (ODNs) can selectively inhibit individual gene expression provided they gain access to and remain stable at the target site for a sufficient period of time. Biodegradable sustained-release delivery systems may facilitate site-specific delivery and also prevent degradation of ODNs by nucleases whilst delivering the nucleic acid in a controlled manner to the desired site of action. In this study, we have characterized biodegradable poly (lactide-co-glycolide) (P(LA-GA)) 50:50 microspheres for the potential delivery of antisense oligonucleotides in vivo. Phosphodiester (PO) oligonucleotides complementary to either c-myc proto-oncogene or the tat gene in HIV-RNA were adequately incorporated within P(LA-GA) microspheres with entrapment efficiencies up to 60% depending on particles size. In vitro release profiles of antisense nucleic acids from 10-20 microm size microspheres over 56 days in physiological buffer were triphasic. Profiles were characterised by an initial burst effect during the first 48 hours (phase 1) of release followed by a more sustained release (phase 2) with an additional increased release (phase 3) being observed after 25 days which corresponded with bulk degradation of the copolymer matrix. The release profiles were influenced by microsphere size, copolymer molecular weight, ODN loading, ODN length and by the pH of release medium used. The serum stability of PO ODNs was significantly improved when entrapped within P(LA-GA) microspheres and the hybridization capability, as assessed by duplex melting (Tm) measurements, of released ODN was not impaired by the double-emulsion microsphere fabrication procedure used. Thus, P(LA-GA) microspheres appear to be promising candidates for improving site-specific delivery profiles for ODNs and are worthy of further evaluation in vivo.
聚(丙交酯-乙交酯)(P(LA-GA))共聚物微球的体外特性研究 反义寡脱氧核苷酸(ODN)只要能够进入靶位点并在该位点保持足够长的时间稳定,就可以选择性地抑制单个基因的表达。可生物降解的缓释递送系统可以促进位点特异性递送,还能防止核酸酶对ODN的降解,同时以可控的方式将核酸递送至所需的作用位点。在本研究中,我们对用于体内反义寡核苷酸潜在递送的可生物降解聚(丙交酯-乙交酯)(P(LA-GA))50:50微球进行了特性研究。与c-myc原癌基因或HIV-RNA中的tat基因互补的磷酸二酯(PO)寡核苷酸被充分包封在P(LA-GA)微球中,包封效率高达60%,具体取决于颗粒大小。在生理缓冲液中,10 - 20微米大小的微球中反义核酸的体外释放曲线呈三相。曲线特征为在释放的前48小时(第1阶段)有一个初始突释效应,随后是更持续的释放(第2阶段),在25天后观察到额外的释放增加(第3阶段),这与共聚物基质的大量降解相对应。释放曲线受微球大小、共聚物分子量、ODN负载量、ODN长度以及所用释放介质的pH值影响。当PO ODN被包封在P(LA-GA)微球中时,其血清稳定性显著提高,并且通过双链解链(Tm)测量评估,释放的ODN的杂交能力并未因所用的双乳液微球制备过程而受损。因此,P(LA-GA)微球似乎是改善ODN位点特异性递送曲线的有前景的候选物,值得在体内进行进一步评估。